Could this drug save cancer Patients' hearing?
NCT ID NCT07407582
Summary
This study is testing if a drug called Pedmark® can protect hearing in adults receiving cisplatin chemotherapy, a common cancer treatment that often causes permanent hearing loss. The drug is already approved for children, but this trial will see if it's safe and effective for adults with solid tumors like testicular, head and neck, or lung cancer. Researchers will give the drug intravenously alongside standard cisplatin treatment and measure hearing changes over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Arizona Cancer Center
Tucson, Arizona, 85724, United States
Contact
Conditions
Explore the condition pages connected to this study.